February 19, 2015 at 01:40PM Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271; Draft Guidance

via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/17uLNCA